ContractClinical Trial Agreement • August 15th, 2017
Contract Type FiledAugust 15th, 2017AMENDMENT NO. 1 TO CLINICAL TRIAL AGREEMENT This Amendment No. 1 to the Clinical Trial Agreement (“Amendment”) is between: Nemocnice Na Františku, having a place of business at Na Františku 847/8, 110 00, Praha 1, Czech Republic, Identification number: 00879 444, Tax identification number: CZ00879444, represented by , director (the “Institution”), and Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 247 68651, Tax identification number: CZ247 68 651 (“Quintiles”), and Kowa Research Institute, Inc., having a place of business at 430 Davis Drive, Suite 200, Morrisville, NC 27560, Tax identification number: 77‐0450319, upon power of attorney represented by Quintiles Czech Republic, s.r.o. (the “Sponsor”). and is effective as of the date last signed below. WITNESSETH: WHEREAS, Quintiles and Institution are parties to an agreement entitled PROMINENT “PEMAFIBRATE TO REDUCE CARD